Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses

T Kieber-Emmons1, P Luo, J Qiu

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104, USA. tom@xray.med.upenn.edu

Nature Biotechnology
|July 15, 1999
PubMed

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...